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Summary: Copper-zinc Superoxide dismutase (Cu,Zn-superoxide dismutase) activity was evaluated in lymphocytes
and polymorphonuclear cells of insulin-dependent (n = 33) and non-insulin-dependent (n = 34) diabetic patients.
A commercial method for the measurement of Superoxide dismutase activity was adapted for use on a discrete
analyser and evaluated for interference by other antioxidants with Superoxide anion-scavenging properties. In com-
parison to healthy control subjects (n = 32), a significantly lower Cu,Zn-superoxide dismutase activity was found
in both lymphocytes and polymorphonuclear cells of insulin-dependent (2.08 ± 0.58 vs. 1.70 ± 0.46 U/mg protein,
p < 0.05, and 1.06 ± 0.46 vs. 0.64 ± 0.40 U/mg protein, p < 0.001, respectively) and non-insulin-dependent dia-
betic patients (2.08 ± 0.58 vs. 1.61 ± 0.48 U/mg protein, p < 0.01, and 1.06 ± 0.46 vs. 0.53 ± 0.24 U/mg protein,
p < 0.001, respectively). There was a weak, but significant negative correlation between age and Cu,Zn-superoxide
dismutase activity in lymphocytes and polymorphonuclear cells (r = —0.22 and r = —0.28, p < 0.05, respectively),
whereas no influence of gender, diabetes duration and glycaemic control was observed. The results indicate that
diabetes mellitus could elicit a significant disturbance in Superoxide anion-scavenging potential of lymphocytes and
polymorphonuclear cells.
Introduction
It has been suggested that oxidative stress, associated
with diabetes mellitus, might play an important role in
the initiation and progression of diabetic complications
(1, 2). Although increased production of toxic free radi-
cals in experimental and human diabetes is well docu-
mented (3), it is likely that diminished activity of the
antioxidant defence system(s) contributes significantly
to the development of oxidative stress (4). Overall anti-
oxidant defence of eukaryotic cells is provided by a vari-
ety of enzymatic and non-enzymatic system(s) (5). Cop-
per-zinc Superoxide dismutase1) in the cytoplasm and
manganese Superoxide dismutase1) in the mitochondria
act as key intracellular scavengers, catalysing dismuta-
tion of commonly produced Superoxide anion radicals to
hydrogen peroxide and molecular oxygen (6).
Both unchanged and diminished Cu,Zn-superoxide dis-
mutase activity in erythrocytes of diabetic patients have
been reported and there are conflicting results regarding
the influence of glycaemic control on dismutase activity
(7—9). It was clearly demonstrated that erythrocyte su-
!) Enzymes:
Superoxide dismutase (Superoxide : Superoxide oxidoreductase;
EC 1.15.1.1)
Xanthine oxidase (xanthine : oxygen oxidoreductase; EC 1.1.3.22)
peroxide dismutase activity was significantly decreased
by in vitro, as well as in vivo glycation (10). There is
little evidence, however, concerning the scavenging po-
tential of the circulating immune cells of diabetic pa-
tients, especially regarding the well documented impair-
ment of the immune system in diabetes mellitus and its
proposed role in the development of diabetic complica-
tions (2,11).
A variety of methods used for the measurement of su-
peroxide dismutase activity are insufficiently standardi-
sed and not easily adaptable for automatic determina-
tion. A modification of the xanthine/xanthine oxidase1)
method, using the dye 2-(p-indophenyl)-3-(p-nitrophe-
nol)-5-phenyl tetrazolium chloride (I.N.T.) (12), was
applied recently in the development of an assay for the
measurement of Superoxide dismutase activity in eryth-
rocytes by Randox Laboratories.
The aim of this study was to adapt the assay for the
automated measurement of Cu,Zn-superoxide dismutase
activity in lymphocytes and polymorphonuclear cells of
diabetic patients by the use of a discrete analyser. Spe-
cial emphasis was given to the evaluation of the possible
contribution of other physiologically relevant superox-
ide anion scavenging compounds to the assay.
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Methods
Lymphocytes and polymorphonuclear cells were isolated from fast-
ing EDTA blood samples (10 ml) according to Boyum with slight
modifications (13). Leukocytes were obtained from the blood with
dextran T-500 (Pharmacia, Uppsala, Sweden, 60 g/1), after sedi-
mentation of erythrocytes (45 min, 25 °C). Lymphocytes and poly-
morphonuclear leukocytes were separated by centrifugation (400 g,
40 min) over Ficoll-Paque (d = 1.077 kg/1, Pharmacia, Uppsala,
Sweden). After lysis of remaining erythrocytes and platelets (cold
EDTA, 10 mmol/1, Kemika, Zagreb, Croatia) and restoring of isoto-
nicity (NaCl, 18 g/1, Kemika, Zagreb, Croatia), lymphocytes and
polymorphonuclear cells were washed (phosphate buffered saline,
pH 7.4, 3X), resuspended in Hank's buffered salt solution (Sigma,
St. Louis, USA), and lysed by the repeated cold shock procedure
(three times freezing at —20 °C, followed by subsequent thawing
at 37 °C). Clear supernatants were collected after centrifugation
(1500 g, 15 min) and frozen (-20 °C) until analysed. Pooled cell
lysates were used for the stability and precision studies.
Cu,Zn-superoxide dismutase activity was measured using the com-
mercial RanSod reagent kit (Randox, Crumlin, Antrim, UK), origi-
nally designed for the determination of Superoxide dismutase in
erythrocytes. Superoxide anion radicals, generated by the xanthine/
xanthine oxidase system, react with electron acceptor 2-(p-indo-
phenyl)-3-(p-nitrophenol)-5-phenyl tetrazolium chloride (I.N.T.)
forming a red formazan dye (absorbance at 500 nm). Superoxide
dismutase activity is measured by the degree of inhibition of this
reaction. The assay was modified for automatic measurement on a
discrete analyser (Spectrum-High Performance Diagnostic System,
Abbott, Chicago, USA). In order to increase assay sensitivity for
the measurement of Cu,Zn-superoxide dismutase activity in lym-
phocytes and polymorphonuclear cells, an automated procedure
using 3.5 times larger sample volumes was designed. The assay
was performed by mixing the xanthine/I. N. T. reagent (236 μΐ)
with 25.0 μΐ of cell lysate, initiating the reaction by subsequent
addition of xanthine oxidase (34.6 μΐ, 80 U/l). The absorbance was
measured after incubation (37 °C, 180 s, 500 nm) and corrected for
the non-specific reduction of I. N. T. by other lysate components
(sample blank). Absorbances were converted into the percentage of
inhibition of the reaction, using reagent blank as 100% (uninhibited
reaction). The assay was calibrated using Superoxide dismutase
standard (5.4 kU/1) provided by the manufacturer; l U is defined
as the enzyme activity causing 50% inhibition of the rate of I.N. T.
reduction under assay conditions (12). For the automated procedure
with increased sensitivity, dilutions of the standard in phosphate
buffered saline, pH 7.4 (0.064, 0.189, 0.375, 0.750 and 1.50 kU/1,
respectively) were found to cover appropriately reaction inhibition
ranging from 15-85%, and used for the construction of the stan-
dard curve [log SOD (kU/1) vs. % inhibition]. Absorbances ob-
tained from cell lysates using this modified procedure gave inhibi-
tions ranging from 30—70%, as recommended in the original as-
say (12).
Inhibition of Cu,Zn-superoxide dismutase with KCN (2.0 mmol/1,
Kemika, Zagreb, Croatia) was used to examine the possible pres-
ence of Mn-superoxide dismutase in cell lysates obtained with the
cold-shock procedure. Interference by other antioxidants with pos-
sible Superoxide dismutase-like activity was evaluated by assaying
saline solutions of albumin, IgG, uric acid, ascorbic acid (all from
Sigma, St. Louis, USA) and soluble tocopherol analogue 6-hy-
droxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Aldrich, Mil-
waukee, USA).
Total protein content in cell lysates was measured by Bradford's
method (14).
Ascorbic acid in cell lysates was measured by the colorimetric
method with a detection limit of 6 μπιοΐ/ΐ (15) using commercially
available reagents (Boehringer, Mannheim, Germany).
HbAlc was measured by ion-exchange chromatography (16),
using FPLC system (Pharmacia, Uppsala, Sweden), and fasting
blood glucose was determined with glucose-oxidase method
using commercially available reagents (Boehringer, Mannheim,
Germany).
All data are expressed as mean values ± S.D. After testing for
normality, comparisons of means were made by one-way analysis
of variance (ANOVA) using CSS software (StatSoft Inc., Tulsa,
USA), followed by Tukey's multiple-comparison procedure in order
to determine which population means are different. Multiple re-
gression analysis was performed to evaluate the relationship be-
tween variables. The differences were considered as statistically
significant at ρ less than 0.05.
Subjects
After informed consent was obtained, blood samples were collected
from 67 diabetic subjects without clinically evident complications,
classified as insulin-dependent (n = 33) and non-insulin-dependent
(n = 34) diabetic patients (17). Additionally, control blood samples
were collected from healthy individuals (n = 32). Characteristics
of the study groups are presented in table 1.
Results
The evaluation of the automated assay for Cu,Zn-super-
oxide dismutase activity in lymphocytes and polymor-
phonuclear cells gave intra- (n = 10) and inter-assay
(n = 20) imprecision (CV) of 3.91% and 5.0%, respec-
tively, whereas sensitivity and linearity were limited
with the range of the standard dilutions used for the
appropriate covering of the degree of reaction inhibition,
amounting to 0.064 kU/1 and 1.5 kU/1. Sample storage
for four (-20 °C) or eight (-80 °C) weeks did not in-
fluence assay results. The addition of Superoxide dismu-
tase from bovine erythrocytes (EC 1.15.1.1, Sigma, St.
Louis, USA) to cell lysates resulted in 102% and 96%
recovery at the levels of activity of 0.28 kU/1 and 1.16
kU/1, respectively (n = 5). The enzyme activity was
found to be 91 and 95% preserved after saline solutions
of Superoxide dismutase (0.50 and 1.20 kU/1, respec-
tively, n = 5) were subjected to the cold-shock pro-
cedure. Superoxide dismutase activity in cell lysates was
100% inhibited by KCN (2.0 mmol/1), indicating that no
mitochondrial Mn-superoxide dismutase was released by
the cold-shock procedure.
The investigation of the possible contribution of physio-
logically relevant antioxidants to the assay showed that
only ascorbate at the upper level of the physiological
concentration in lymphocytes [700 μηιοΐ/ΐ, as reported
by Lee et al. (18)], exhibited low Superoxide dismutase-
like activity (0.19kU/l), whereas no detectable activity
was elicited by saline solutions of albumin, IgG, uric
acid and 6-hydroxy-2,5,7,8-tetramethylchroman-2-car-
boxylic acid (20 g/1, 3 g/1, 0.5 mmol/1 and 25 mmol/1,
respectively). However, no ascorbate was measured in
lysates of lymphocytes and polymorphonuclear cells,
obtained by the repeated cold-shock procedure.
Cu,Zn-superoxide dismutase activities measured in lym-
phocytes and polymorphonuclear cells isolated from the
blood of diabetic patients and healthy controls were nor-
malised to the total protein content of cell lysates. Dis-
mutase activities from both cell types were not found to
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be influenced by gender, smoking habits and duration of
the disease. Simple correlation analysis found a weak
but significant negative relationship between age and
Cu,Zn-superoxide dismutase activity in lymphocytes
and polymorphonuclear cells (r = —0.22, p < 0.05 and
r = -0.28, ρ < 0.05, respectively, figs 1 and 2).
Multiple regression analysis identified age as a signifi-
cant determinant of lymphocyte (t = — 2.11, R2 = 0.05,
ρ = 0.04) and polymorphonuclear (t = —2.58,
R2 = 0.08, ρ = 0.01) SOD activity in the diabetic sub-
jects, whereas no influence of diabetes duration, blood
glucose and HbAlc was found.
Significantly lower Cu,Zn-superoxide dismutase activity
was found in lymphocytes of both insulin-dependent and
non-insulin-dependent diabetic patients when compared
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Fig. 1 Relation between age (years) and Cu,Zn-superoxide dis-
mutase activity (U/mg total protein) in lymphocytes of the patients
with insulin-dependent (Π, η = 33), non-insulin dependent diabetes
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Fig. 2 Relation between age (years) and Cu,Zn-superoxide dis-
mutase activity (U/mg total protein) in polymorphonuclear leuko-
cytes of the patients with insulin-dependent (D, n = 33), non-insu-
lin dependent diabetes mellitus (·, n = 34) and healthy control
subjects (A, n = 32).
2.06 ± 0.58 U/mg total protein, p < 0.05, respectively).
An even more significant difference was observed in
polymorphonuclear cells of patients with insulin-depen-
dent and non-insulin-dependent diabetes when compared
to controls (0.62 ± 0.39 and 0.51 ± 0.24 vs. 1.06
± 0.43 U/mg total protein, p < 0.001, respectively).
Dismutase activities in both cell types were higher in
insulin-dependent than non-insulin-dependent subjects,
but the difference was not significant. Although the sub-
jects with non-insulin-dependent diabetes were older
than those with insulin-dependent diabetes and healthy
controls, and age was identified as an independent
factor, adjusting for age did not affect the difference in
the Cu,Zn-superoxide dismutase activity between the
subjects studied (fig. 3).
Discussion
Persistent hyperglycaemia correlates highly with the de-
velopment of late diabetic complications (19). However,
the mechanisms involved in the progression of retinopa-
thy, neuropathy and nephropathy are still unclear. A
large body of evidence suggests that oxidative stress
might play a significant role in the development of dia-
betic complications. The mechanisms connecting hyper-
glycaemia and oxidative stress implicate a complex













Fig. 3 Age-adjusted Cu,Zn-superoxide dismutase activity (U/mg
total protein) in lymphocytes and polymorphonuclear leukocytes in
33 patients with insulin-dependent D, 34 patients with non-insulin-
dependent diabetes mellitus · and 32 healthy control subjects ·.
Levels of significance: "p < 0.05, bp < 0.001 vs. healthy controls.
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cation of proteins and oxidation of associated lipids (1,
2). Generation of oxygen free radicals during these in-
teractions has been confirmed by the findings of
increased Superoxide anion radical production in both
plasma and polymorphonuclear leukocytes of diabetic
patients (20, 21). Although Superoxide dismutases pro-
vide effective intracellular defence against Superoxide
radical-mediated toxicity, this scavenging system might
be impaired in diabetes due to diminished synthesis and/
or deactivation of the enzymes by glycation (10).
Attempts to evaluate the Superoxide dismutase activity
in diabetic patients demonstrated inconsistent results
(7-9).
This could, at least in part, be attributable to the unstan-
dardised methodology applied to the measurements of
Superoxide dismutase activity. In the present study a
rapid, simple and reliable automated procedure for the
measurement of Cu,Zn-superoxide dismutase activity in
lymphocytes and polymorphonuclear cells is described.
The procedure can be applied to the measurement of
Superoxide dismutase activity in various biological sys-
tems (22, 23). Increased sensitivity of the measurement
enables sufficient cell isolation from as little as 10 ml of
whole blood. No interference from mitochondrial Mn-
superoxide dismutase and other physiologically relevant
antioxidants, with the exception of ascorbic acid, was
detected. Nevertheless, no ascorbate was detected in the
cell lysates, and it was presumed that ascorbate, due to
its unstability, underwent degradation during cell isola-
tion and lysis by the cold-shock procedure. Thus, ascor-
bate interference in this assay seems unlikely.
The results of this study indicate that Cu,Zn-superoxide
dismutase activity is significantly lower in circulating
immune cells of insulin-dependent and non-insulin-de-
pendent diabetic patients, when compared to healthy
controls. The results obtained in polymorphonuclear
cells are in accordance with the previous observation
in newly diagnosed, unclassified diabetic patients (21),
exhibiting for the first time that a decrease of Cu,Zn-
superoxide dismutase activity persists in both insulin-
dependent and non-insulin-dependent diabetic patients.
Furthermore, these findings are supported by the recent
report on diminishing polymorphonuclear dismutase ac-
tivity in the course of the development of insulin-depen-
dent diabetes mellitus in first-degree relatives of diabetic
patients (24). Significantly lower Cu,Zn-superoxide dis-
mutase activity in lymphocytes of diabetic patients con-
firms our preliminary report on the impaired antioxidant
defence in insulin-dependent diabetes (25), indicating
that diabetes itself, regardless of the type, might elicit
disturbances in the cellular protection against Superoxide
radical-mediated toxicity. Although unchanged lympho-
cyte Superoxide dismutase activity in diabetic children
has been reported (26), our results obtained in the group
of adult patients may not necessarily be discrepant since,
considering the significant negative correlation be-
tween age and Cu,Zn-superoxide dismutase activity, it
is likely that both the ageing process and diabetes
mellitus might be involved in the decrease of the
enzyme activity. The lack of influence of blood glu-
cose and HbAlc on Cu,Zn-superoxide dismutase activ-
ity, apart from the relatively short life span of leuko-
cytes, indicates that the decreased activity in lympho-
cytes and polymorphonuclear leukocytes could hardly
be ascribed to the time-requiring process of enzyme
glycation, as it was suggested for the dismutase in the
erythrocytes (10).
Diminished Cu,Zn-superoxide dismutase activity in
lymphocytes and polymorphonuclear cells of diabetic
patients could also indicate a complex disturbance of
immune cell metabolism in diabetes mellitus, affected
by both hyperglycaemia and hypoinsulinaemia (11). It is
important to emphasize that diabetic patients did not
have evident complications at the time of the study, sug-
gesting that the impairment of defence systems against
Superoxide radical-mediated toxicity in circulating im-
mune cells precedes the clinical onset of complications.
Whether or not this defence system is involved in the
progression of diabetic complications remains to be fur-
ther elucidated. Functional and biochemical investiga-
tions of circulating immune cells offer a plausible exper-
imental model for in vitro studies of both immunological
and metabolic alterations in diabetes mellitus which may
lead to the development of diabetic complications. The
measurement of Cu,Zn-superoxide dismutase activity by
the use of a rapid, simple and reliable automated pro-
cedure is likely to be a valuable tool in attaining this
goal.
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